Use of chitosan in the treatment of obesity: evaluation of interaction with vitamin B12.

Is well known that obesity has increased significantly in recent times and therefore many dietary supplements, synthetic or natural, have been proposed in order to prevent and/or to treat obesity or overweight. Chitosan, a polysaccharide with ability to act as a carrier and to absorb fat, has been used for this purpose. However, interactions with other molecules present in the body may also occur and, therefore, the purpose of this study was to evaluate interactions of chitosan with vitamin B12.

Spectrofluorimetric determination of DL-N-methyl-3-phenyl-3-[(α,α,α-trifluoro-p-tolyl)oxy]propylamine in pharmaceuticals and chitosan solution.

A spectrofluorimetric method for the determination of D,L-N-methyl-3-phenyl-3-[(α,α,α-trifluoro-p-tolyl)oxy]propylamine, fluoxetine (F), in pharmaceuticals was evaluated in the 50.0-500.0 μg ml⁻¹ range.

Use of chitosan in the treatment of obesity: evaluation of interaction with vitamin B2.

Obesity is a serious health problem and its prevalence has increased over the years. Studies have assessed the polysaccharide chitosan as anti-obesity supplement due to its ability to absorb fats. However, this property may cause the interaction of chitosan with essential substances for the proper functioning of the body, such as vitamins.